Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income 273.11 M272.06 M272.75 M292.11 M269.1 M281.76 M 1.12 B Non-Operating Income, Total -5.28 M-9.47 M-5.1 M-5.46 M-8.14 M-4.35 M -23.05 M Interest expense, net of interest capitalized 12.29 M12.3 M12.9 M12.46 M12.37 M12.48 M 50.22 M Non-Operating Income, excl. Interest Expenses -17.57 M-21.77 M-18 M-17.93 M-20.5 M-16.84 M -73.27 M Unusual income/expense —————— — Pretax income 211.42 M214.5 M209.83 M223.09 M213.38 M219.97 M 866.26 M Equity in earnings —————— — Taxes 45.64 M46.69 M46.33 M45.92 M45.61 M45.13 M 183 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 165.78 M167.81 M163.5 M177.16 M167.77 M174.84 M 683.27 M Discontinued operations —————— — Net income 165.78 M167.81 M163.5 M177.16 M167.77 M174.84 M 683.27 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 165.78 M167.81 M163.5 M177.16 M167.77 M174.84 M 683.27 M Basic earnings per share (Basic EPS) 1.091.121.111.221.181.25 4.76 Diluted earnings per share (Diluted EPS) 1.081.111.11.231.181.25 4.76 Average basic shares outstanding 151.83 M149.94 M147.43 M148.37 M141.59 M139.5 M — Diluted shares outstanding 152.91 M150.73 M148.34 M149.32 M142.63 M140.31 M — EBITDA 276.3 M269.3 M268.82 M289.31 M265.84 M278.7 M 1.1 B EBIT 273.11 M272.06 M272.75 M292.11 M269.1 M281.76 M 1.12 B Cost of revenue 30.54 M25.29 M35.88 M17.81 M37.16 M33.26 M 124.12 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) -3.06 M-2.75 M-3.92 M-2.8 M-3.25 M-3.06 M -13.04 M